Bukharin O V, Valyshev A V, Chelpachenko O E, Elagina N N, Perunova N B
Institute of Cellular and Intracellular Symbiosis of the Urals Branch, Russian Academy of Sciences, Medical Academy, Orenburg, Russia.
Zh Mikrobiol Epidemiol Immunobiol. 2002 Jul-Aug(4):55-7.
Clinical and bacteriological studies have revealed that the production of colicin by Escherichia coli forming a part of intestinal microbiocenosis is related to the clinical manifestations of inflammatory diseases of the gastrointestinal tract. During the exacerbation of chronic inflammatory processes of the digestive system the proportion of colicin producing E. coli increases (more than 45%) in comparison with that of E. coli fecal strains isolated in children and adolescents regarded as healthy (less than 15%). The possibility of using the colicin producing activity of intestinal microflora for the evaluation of the dysbiotic states of gastrointestinal tract is discussed.
临床和细菌学研究表明,作为肠道微生物群落一部分的大肠杆菌产生的大肠杆菌素与胃肠道炎症性疾病的临床表现有关。在消化系统慢性炎症过程加重期间,与被视为健康的儿童和青少年中分离出的大肠杆菌粪便菌株(少于15%)相比,产生大肠杆菌素的大肠杆菌比例增加(超过45%)。本文讨论了利用肠道微生物群产生大肠杆菌素的活性来评估胃肠道生态失调状态的可能性。